Tanvex BioPharma
6541.TW
0.93 USD
-0.03
-3.12%
t
Overview
Last close
0.93 usd
Market cap
246.40M usd
52 week high
2.12 usd
52 week low
0.93 usd
Target price
1.61 usd
Valuation
P/E
N/A
Forward P/E
N/A
Price/Sales
12.1906
Price/Book Value
2.8501
Enterprise Value
456.14M usd
EV/Revenue
133.8492
EV/EBITDA
-9.0582
Key financials
Revenue TTM
20.19M usd
Gross Profit TTM
-27.59M usd
EBITDA TTM
-39.86M usd
Earnings per Share
-0.17 usd
Dividend
N/A usd
Total assets
240.14M usd
Net debt
46.90M usd
About
Tanvex BioPharma, Inc., a pharmaceutical company, engages in the research, development, manufacture, and sale of biosimilar products in Taiwan and the United States. The company focuses on delivering biopharmaceuticals with biosimilars targeting neutropenia, breast cancer, metastatic colorectal cancer, and psoriasis. It also engages in contract development and manufacturing of biological medicines. The company was founded in 2011 and is headquartered in George Town, the Cayman Islands.
- Symbol6541.TW
- ExchangeTW
- IsinKYG8676P1037
- CountryCayman Islands
- SectorHealthcare
- IndustryBiotechnology
- CEO
- HeadquarterGeorge Town
- Web sitehttps://www.tanvex.com
